JPRN-UMIN000020295已完成未知
A Study on Predictors of Treatment Response to Simeprevir, Peg-interferon and Ribavirin combination therapyin Patients with genotype Chronic Hepatitis C Virus Infection - Predictors of treatment response to SMV/Peg-IFN/RBV therapy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with poorly controlled cardiac disease (e.g., myocardial infarction, cardiac failure, arrhythmia) 2)Patients with severe hepatic impairment 3)Patients with a history of hypersensitivity to HCV protease inhibitors or Ribavirin 4)Patients with a concurrent malignancy, including hepatocellular carcinoma, at the start of treatment 5)Patients deemed unsuitable for study entry by their treating physician 6) Patients with severe renal dysfunction 7)Patients who are unsuitable, in the opinion of the principal investigator, for this study due to any other reason
研究者
相似试验
已完成
不适用
A Study on Predictors of Treatment Response to Sofosbuvir and Ribavirin Therapy in Patients with genotype 2 Chronic Hepatitis C Virus InfectioPatients with genotype 2 HCV infectionJPRN-UMIN000018947Hokkaido University Department of Gastroenterology and Hepatology, Graduate School of Medicine,260
已完成
不适用
A Study on Predictors of Treatment Response to Sofosbuvir and Ledipasvir Therapy in Patients with genotype 1 Chronic Hepatitis C Virus InfectioPatients with genotype 1 HCV infectionJPRN-UMIN000019011Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University260
招募中
不适用
A prospective study of treatment response of patients with myelofibrosis and PNH type blood cellsmyelofibrosisJPRN-UMIN000045859Juntendo University100
已完成
不适用
A Study on Predictors of Treatment Response to ombitasvir/paritaprevir/r combination therapy in Patients with genotype 1 Chronic Hepatitis C Virus InfectioPatients with genotype 1 HCV infectionJPRN-UMIN000020299Hokkaido University260
已完成
不适用
Studies on the predictive factors of treatment outcome after intravitreal injection of Lucentis (ranibizumab) in eyes with macular edema associated with central retinal vein occlusion (CRVO)Central retinal vein occlusionJPRN-UMIN000012793Ophthalmology, Mie University Hospital30